ºÚÁϲ»´òìÈ’s reduced-risk product (RRP) ISO/IEC 17025:2017, UKAS accredited testing laboratory (No. 1938) gives customers a pathway to successfully submitting a premarket tobacco application (PMTA) for electronic nicotine delivery systems (ENDS), alternative nicotine delivery systems (ANDS), and other next generation products (NGP). Partner with us to demonstrate that your reduced-risk products comply with regulation and are suitable for end-user consumption.
EU TPD2 & UK TRPR Submissions
ºÚÁϲ»´òìÈ’s labs provide comprehensive testing services for e-cigarettes and e-liquids, supporting submission of high-quality RRP technical notifications for regulatory compliance with TPD2 and UK TRPR.
In late 2013, the European Commission finalised the text to the Tobacco Products Directive (TPD2) and included requirements for both manufacturers and importers of nicotine-containing e-cigarettes under Article 20. The UK was one of the early adopters of this EU directive into national regulation, and the Tobacco and Related Products Regulations came into force on 20th May 2016, amended to The Tobacco Products and Nicotine Inhaling Products Regulations in 2020 (EU Exit).
Partner with ºÚÁϲ»´òìÈ to complete your TPD2/TRPR product notifications and bring each new RRP to market legally and on time. Our experts have many years of relevant scientific and regulatory experience that we utilise to ensure clients fulfil all statutory regulatory requirements for the supply of nicotine reduced-risk products to EU/UK consumers.